News

Filter

Current filters:

None

7880 to 7889 of 95987 results

Clinical market in CIS to exceed $940 million euros in 2014

12-02-2012

Clinical trials in the Commonwealth of Independent States (CIS) countries have been developing in a positive…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

EMA guidelines on pharmacogenetics in evaluating pharmacokinetics of medicines

12-02-2012

The European Medicines Agency on Friday published a guideline advising pharmaceutical companies how to…

BiotechnologyEuropePharmaceuticalRegulationResearch

IPHA CEO warns on reference drug pricing plans in Ireland

12-02-2012

With the Irish government planning to introduce a bill for a reference pricing system in 2012, serious…

EuropePharmaceuticalPoliticsPricing

At last, draft guidance on biosimilars pathway from US FDA

10-02-2012

Coming somewhat behind European Union action, the US Food and Drug Administration late yesterday issued…

BiotechnologyGenericsNorth AmericaRegulation

Cytomedix expands in regenerative medicines, buying Aldagen

10-02-2012

USA-based regenerative wound care specialist Cytomedix (OTC.BB: CMXI.OB) said yesterday that it has…

AldagenCytomedixMergers & AcquisitionsPharmaceutical

Shire forecasts strong 2012 EPS growth on record 2011 sales; Vyvanse news

10-02-2012

Shire (LSE: SHP), the UK’s third-largest drugmaker, posted a pleasing set of financial for full-year…

FinancialNeurologicalNorth AmericaPharmaceuticalRegulationShireVyvanse

Hospira challenges Cubist patents on Cubicin

10-02-2012

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

Further protests from activists against EU and India FTA

10-02-2012

As India and the European Union meet today for a Summit in New Delhi to iron out the differences over…

Asia-PacificEuropeGenericsMarkets & MarketingPatentsPharmaceuticalPolitics

Celgene makes $15 million investment in Acetylon

10-02-2012

US biotech Celgene (Nasdaq: CELG) will invest a total of $15 million in Acetylon Pharmaceuticals via…

Acetylon PharmaceuticalsBiotechnologyCelgeneFinancial

7880 to 7889 of 95987 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top